Business Context and Reporting Period
Company: Oragenics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 25, 2007
Reporting Period: The filing addresses the Company's status following the review of its Form 10-KSB for the fiscal year ended December 31, 2006.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it discloses the following financial conditions triggering regulatory action:
- Shareholders' Equity: Less than $2,000,000.
- Profitability: The Company reported losses from continuing operations and/or net losses in two of its most recent fiscal years.
Material Changes and Listing Status
On April 25, 2007, Oragenics, Inc. received notice from the American Stock Exchange (AMEX) that its Common Stock (Symbol: ONI) failed to meet continued listing standards. Specifically, the Company is non-compliant with Section 1003(a)(i) of the AMEX Guide due to insufficient shareholders' equity and recurring net losses.
Outlook, Management Commentary, and Risks
Required Action: The Company must submit a compliance plan to the AMEX by May 25, 2007, detailing actions to regain compliance by October 27, 2008.
Management Expectation: The Company expects to submit the required plan by the May 25 deadline.
Risks and Contingencies:
- There is no assurance the AMEX will accept the Company's plan.
- If the plan is not accepted, the Company will be subject to delisting proceedings.
- If the plan is accepted, the listing will be subject to periodic reviews to ensure progress.
Investor Verification Checklist
- Verify the exact amount of shareholders' equity as of December 31, 2006, in the Form 10-KSB.
- Confirm the specific net loss figures for the two most recent fiscal years.
- Monitor the submission of the compliance plan by May 25, 2007.
- Watch for AMEX's determination on the acceptance of the plan and any subsequent delisting notices.